Z-1540-2021 Class II Terminated
FDA device recall Z-1540-2021 was initiated by Meridian Bioscience Inc on Apr 8, 2021 and is designated Class II. Reason for recall: Emergency Use Application (EUA) application withdrawn as false negative results reported The recall status is terminated (terminated Oct 26, 2021). Affected quantity: 376 kits of the Revogene SARS-CoV-2 assay.
Recall details
- Product Type
- Devices
- Report Date
- May 19, 2021
- Initiation Date
- Apr 8, 2021
- Termination Date
- Oct 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 376 kits of the Revogene SARS-CoV-2 assay
Product description
Revogene SARS-CoV-2 Catalog Number: 410700 IVD for real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene¿ instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal swab (NPS) specimens from individuals suspected of COVID-19
Reason for recall
Emergency Use Application (EUA) application withdrawn as false negative results reported
Distribution pattern
Nationwide
Code information
All lot numbers
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1540-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026